PRESS DIGEST- Financial Times - Feb 20
Feb 20 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Jan 10 Pluristem Therapeutics Inc
* Pluristem's Phase III study of PLX-PAD cells for the treatment of critical limb ischemia cleared by U.S. FDA
* Pluristem expects to begin enrolling patients in its Phase III study in both U.S. and Europe during first half of 2017 Source text for Eikon: Further company coverage:
NEW YORK, Feb 19 U.S. food company Kraft Heinz Co withdrew its proposal for a $143-billion merger with larger rival Unilever Plc, the companies said on Sunday, raising questions about whether Kraft will turn its focus to another target.
LONDON, Feb 17 John Fallon needs to show he has a plan to navigate Pearson through the sinking sands of its main markets when the world's biggest education company reports full-year results.